LOGIN  |  REGISTER
C4 Therapeutics
Compass Therapeutics

AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions

July 02, 2025 | Last Trade: US$20.53 0.99 5.07
  • Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management

DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent solutions, today announced the sale of its Smart Square® scheduling software to symplr®, a leader in enterprise healthcare operations software. In addition to the acquisition, symplr and AMN have entered into a commercial partnership that ensures customers get the best of both worlds: symplr’s excellence in operational technology and AMN’s leadership in healthcare workforce solutions.

“Healthcare organizations are navigating unprecedented workforce complexity. This deal advances our focus on the workforce planning, analytics, and AI capabilities of our WorkWise platform, while seamlessly integrating WorkWise into our clients’ scheduling and operational tools through strategic technology partnerships, like this one with symplr,” said Cary Grace, president and CEO at AMN Healthcare.

Healthcare organizations increasingly demand integrated, efficient workforce management solutions that work together effortlessly. By uniting AMN’s unmatched strategic workforce advisory, planning and analytics solutions with symplr’s workforce software, the combined capabilities will streamline workforce optimization, scheduling, timekeeping, and administrative processes for hospitals and health systems nationwide.

“A critical way for hospitals and health systems to unlock greater value from their technology is to arm them with intelligent, purpose-built software,” said BJ Schaknowski, CEO of symplr. “Bringing Smart Square’s AI-driven scheduling engine into the symplr Operations Platform helps us stay ahead of the emerging and dynamic needs of the healthcare workforce.”

This commercial partnership enhances AMN's WorkWise technology suite by intelligently connecting clients with additional digital offerings that extend workforce management systems clients already use. By aligning with best-in-class partners like symplr for enhanced functionality, AMN can deliver an end-to-end solution for planning, staffing, scheduling, talent acquisition, and workforce deployment that adapts to the evolving workforce needs of healthcare organizations.

The total purchase price was $75 million, with $65 million paid at closing and a $10 million note due at the end of 2026.

About AMN Healthcare  

AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2024 our healthcare professionals reached nearly 15 million patients at more than 2,100 healthcare systems, including 87 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies. For more information, visit www.amnhealthcare.com.

About symplr

symplr is a leader in enterprise healthcare operations software and services with a first-of-its-kind operations platform. Trusted in 9 of 10 U.S. hospitals and 400+ U.S. health plans, symplr optimizes operations and maximizes care powered by our cloud-based workforce, quality, provider data management, and spend solutions. Gain efficiency, reduce complexity, and improve outcomes where it matters most. Learn how to stay ahead of change at www.symplr.com.

Media Contact 
Corporate Communications 
AMN Healthcare 
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact 
Randle Reece 
Vice President, Investor Relations
AMN Healthcare 
(866) 861-3229 
This email address is being protected from spambots. You need JavaScript enabled to view it.

Assertio

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page